FHI Clinical provides specialized support for a broad range of therapeutic areas in clinical research.
We are experts in infectious disease clinical trials, including outbreaks of Ebola, COVID-19, influenza, HIV, tuberculosis, malaria, and Zika. Our ability to respond rapidly in public health emergencies is unmatched.
We specialize in both solid tumors and hematologic oncology in early phase development, delivering comprehensive research support. Our global footprint enables us to conduct oncology studies wherever they are most advantageous. We support clients from IND planning through proof of concept, ensuring strategic and effective study execution.
Beyond Infectious Disease and Oncology, our work spans other therapeutic areas that include cardiology, autoimmune, gastroenterology, hematology, neurology, and nutrition. This portfolio of studies has been conducted across a variety of patient populations, geographic regions and phases. Vaccine studies represent almost 25% of our work.
Have questions or need more information? Reach out to our team—we’re here to help and eager to connect.
"*" indicates required fields
We envision a world where advances in vaccines and medicines help all people live longer, healthier lives.
359 Blackwell Street, Suite 200, Durham, NC 27701 USA
Britam Towers, 24th Floor, Hospital Road, Upper Hill KENYA
3A Cinsaut House Dorpstreet, The Vinevard Office Estate, Bellville, Western Cape, 7530, South Africa
The Cape Hotel, Mamba Point, Monrovia LIBERIA
Camino Real a Tetelpan #207, Colonia Tetelpan, Delegación Alvaro Obregon, Ciudad México, CP 01700, Mexico
Powered by BaseCloud
